Antibody · 알츠하이머 · 항아밀로이드

2개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2 programs
AntibodyCurated CoreFDAEisaiApproved

lecanemab (Leqembi, BAN2401, lecanemab-irmb)

Early symptomatic Alzheimer's disease (MCI or mild dementia) with confirmed amyloid pathology · Amyloid-beta protofibrils

#Amyloid-betaprotofibrils#Antibody#Approved#FDA-approved#BioJungboMoa-pick+4
Trials 37Status Approved
AntibodyCurated CoreFDAEli LillyApproved

donanemab (Kisunla, LY3002813, donanemab-azbt)

Early symptomatic Alzheimer's disease with confirmed amyloid pathology · N3pG amyloid-beta plaque

#N3pGamyloid-betaplaque#Antibody#Approved#FDA-approved#BioJungboMoa-pick+4
Trials 21Status Approved